Skip to product information
1 of 1

FLT-3L Protein, Human

FLT-3L Protein, Human

Catalog Number: UA040478 Brand: UA BIOSCIENCE
Price:
Regular price $160 USD
Regular price Sale price $160 USD
Size:
For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Species Human
Synonyms Fms-related tyrosine kinase 3 ligand,Flt3 ligand,Flt3L,SL cytokine,
Accession P49771
Amino Acid Sequence Thr27-Pro185, with C-terminal hFc Tag
Expression System HEK293
Molecular Weight

55-65 kDa (Reducing)

Purity >95% by SDS-PAGE and HPLC.
Endotoxin <0.1EU/μg
Conjugation Unconjugated
Tag Human Fc Tag
Physical Appearance Lyophilized powder
Storage Buffer

PBS, pH7.4

Reconstitution

Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.

Stability & Storage

·12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
·3 months, -20 to -80℃ under sterile conditions after reconstitution.
·1 week, 2 to 8℃ under sterile conditions after reconstitution.
·Please avoid repeated freeze-thaw cycles.

Reference

Blood. 2002 Sep 1;100(5):1532-42.
Nature. 1994 Apr 14;368(6472):643-8.

Background

Fms-like tyrosine kinase 3 ligand (Flt-3 Ligand, or FLT3L) is an alpha-helical cytokine that regulates hematopoiesis by promoting the survival, proliferation, and differentiation of hematopoietic stem and progenitor cells (including dendritic cells, NK cells, and B cells) through binding to the Flt3 receptor (Flt3/Flk-2) and activating the STAT3 signaling pathway. It is expressed as a noncovalently-linked dimer by T cells and bone marrow/thymic fibroblasts and exists in both transmembrane and soluble forms. FLT3L synergizes with other cytokines (e.g., IL-3, GM-CSF, SCF, IL-2, IL-6, IL-7, and IL-15) to enhance hematopoietic cell mobilization, differentiation, and immune cell development.
Recombinant human FLT3L is used in hematopoietic stem cell (HSC) culture expansion (e.g., with SCF and TPO) and dendritic cell (DC) differentiation (e.g., for immunotherapy applications). FLT3L has also been explored as an adjuvant in therapeutic vaccines (e.g., cancer and infectious disease vaccines) to enhance antigen-specific T cell responses or DC mobilization.

Picture

SDS-PAGE

2μg (R: reducing condition, N: non-reducing condition).

RP-HPLC

>95% as determined by RP-HPLC.

ELISA

Immobilized Flt-3/Flk-2 Protein, Human (Cat. No. UA040247) at 1.0μg/mL (100μL/well) can bind Flt-3L Protein, Human Fc Tag (Cat. No. UA040478) with EC50 of 6.79-13.12ng/ml.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)